Researchers presented a small-molecule compound D6 which selectively inhibited tumor cell growth and migration in NSCLC cells with EGFR-TKI-resistant T790M-EGFR-activated mutations.
[Communications Biology]
Sorry, but the selected Zotpress account can't be found.